Rare genetic disorders, which affect millions globally but lack effective treatments, represent the most immediate and impactful therapeutic application for gene editing technologies. These diseases, often caused by a single gene mutation, are ideally suited for correction using precise tools like CRISPR. Sickle Cell Disease (SCD) and Beta-Thalassemia have emerged as flagship successes,...